The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Sukhanov D.S.
Sankt-Peterburgskaia gosudarstvennaia meditsinskaia akademiia im. I.I. Mechnikova
Immunotropic therapy for tuberculosis infection
Journal: Therapeutic Archive. 2013;85(3): 110‑117
Views: 8434
Downloaded: 262
To cite this article:
Sukhanov DS. Immunotropic therapy for tuberculosis infection. Therapeutic Archive. 2013;85(3):110‑117. (In Russ.)
The review summarizes current views on the immunopathogenesis of tuberculosis infection. It shows the leading role of a Th1 cytokine response in the formation of antituberculosis protective immunity and the impact of cytokine balance on disease outcomes. Data on the efficacy of current groups of immunomodulators used in the therapy of tuberculosis (immunomodulators, peptides, cytokine preparations, and synthetic immunomodulators of different chemical structures) are considered. Particular emphasis is placed on a group of interferon inducers as drugs for pathogenetic therapy, of which cycloferon is most important. The data of studies of the effect of cycloferon on the elaboration of interferon-γ that is able to activate a Th1 immune response, which promotes the shorter time of abacillation and decay cavity closure and positive X-ray changes, are given.
Authors:
Sukhanov D.S.
Sankt-Peterburgskaia gosudarstvennaia meditsinskaia akademiia im. I.I. Mechnikova
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.